Effect of patient-initiated versus fixed-interval telePRO-based outpatient follow-up: study protocol for a pragmatic randomised controlled study by Liv Marit Valen Schougaard et al.
STUDY PROTOCOL Open Access
Effect of patient-initiated versus
fixed-interval telePRO-based outpatient
follow-up: study protocol for a pragmatic
randomised controlled study
Liv Marit Valen Schougaard1*, Caroline Trillingsgaard Mejdahl2,6, Klaus Hvam Petersen1, Anne Jessen1,
Annette de Thurah2,3,4, Per Sidenius5, Kirsten Lomborg2,4,6 and Niels Henrik Hjollund1,7
Abstract
Background: The traditional system of routine outpatient follow-up of chronic disease in secondary care may
involve a waste of resources if patients are well. The use of patient-reported outcomes (PRO) could support more
flexible, cost-saving follow-up activities. AmbuFlex is a PRO system used in outpatient follow-up in the Central
Denmark Region. PRO questionnaires are sent to patients at fixed intervals. The clinicians use the PRO data to
decide whether a patient needs a visit or not (standard telePRO). PRO may make patients become more involved in
their own care pathway, which may improve their self-management. Better self-management may also be achieved
by letting patients initiate contact. The aim of this study is to obtain data on the effects of patient-initiated follow-up
(open access telePRO) on resource utilisation, quality of care, and the patient perspective.
Methods: The study is a pragmatic, randomised, controlled trial in outpatients with epilepsy. Participants are randomly
assigned to one of two follow-up activities: a) standard telePRO or b) open access telePRO. Inclusion criteria are age≥
15 years and previous referral to standard telePRO follow-up at Aarhus University Hospital, Denmark. Furthermore,
patients must have answered the last questionnaire via the Internet. The number of contacts will be used as the
primary outcome measure. Secondary outcome measures include well-being (WHO-5 Well-Being Index), general
health, number of seizures, treatment side effects, mortality, health literacy (Health Literacy Questionnaire), self-efficacy
(General Self-Efficacy scale), patient activation, confidence, safety, and satisfaction. In addition, the patient perspective
will be explored by qualitative methods. Data will be collected at baseline and 18 month after randomisation. Inclusion
of patients in the study started in January 2016. Statistical analysis will be performed on an intention-to-treat and
per-protocol basis. For qualitative data, the interpretive description strategy will be used.
Discussion: The benefits and possible drawbacks of the PRO-based open access approach will be evaluated. The
present study will provide important knowledge to guide future telePRO interventions in relation to effect on resource
utilisation, quality of care, and the patient perspective.
Trial registration: ClinicalTrials.gov: NCT02673580 (Registration date January 28, 2016)
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Background
The Danish health care system is changing from in-
patient towards a greater outpatient activity. From 2002
to 2009, there was a 50% increase in outpatient activity
in Denmark, primarily related to the number of contacts
per patient [1]. At the same time, there appears to be a
growing need of health care services especially for the
growing group of patients with chronic diseases and an
increased focus on patient involvement. The challenge is
to manage this without compromise on quality of care
and patient outcomes. Follow-up visits for patients with
chronic diseases in secondary care are traditionally based
on regular pre-booked visits, which may be arranged
when the patient is well. Thus patients as well as clini-
cians may find such visits unnecessary. The volume of
appointments leads to capacity issues in outpatient
clinics that struggle to respond rapidly to patients’ re-
quests for help [2].
One way of handling this challenge may be to let pa-
tients report essential information on health status and
symptoms from home before or instead of visiting the
outpatient clinic. Patients’ own reports on health condi-
tion are termed patient-reported outcomes (PRO). The
American Food and Drug Agency definition of PRO, “A
measurement based on a report that comes directly from
the patient about the status of a patient’s health condi-
tion without interpretation of the patient’s response by a
clinician or anyone else” [3], focuses on the source of in-
formation and points out the importance of the patient
perspective. The use of PRO in clinical practice is be-
coming increasingly common, and studies have reported
improved patient-clinician communication, more effect-
ive self-management, and better utilisation of resources
when PROs are used, whereas findings related to effects
on patient outcomes are less consistent [4–7].
PRO may facilitate patient involvement because the
problems reported as important by the patient are taken
into consideration in the decision-making process [8–
10]. However, patient involvement is not a goal in itself
but rather a means to increase the patient’s self-
management. Self-management refers to the individual’s
ability to manage symptoms, treatment, physical and
psychosocial consequences, and life style changes inher-
ent in life with a chronic disease [11]. In practice, PRO
is supposed to promotes a patient-centred dialogue be-
tween the patient and the clinicians in which the pa-
tient’s view and opinion on his health are included.
Thus, implementing PRO into clinical practice allows
patients to actively participate in their own care, by
which their self-management may improve [8].
AmbuFlex is a generic clinical PRO system which is
not limited to specific patient groups, organisations or
medical record systems [12]. As of December 2015,
AmbuFlex had been implemented in nine patient groups
at 15 outpatient clinics in Denmark [13]. An analysis ini-
tiated by the Danish government based on experiences
with AmbuFlex has demonstrated a positive national
business case and considerable quality gain [14]. The
Danish government and Danish regions, who run the
public hospitals, have decided on an agreement for na-
tionwide implementation of PRO in three diagnostic
group, including epilepsy, before 2020. AmbuFlex was
implemented for epilepsy outpatients at Aarhus Univer-
sity Hospital in March 2012 and is now used at three
neurological departments in the Central Denmark Re-
gion. As of August 2016, 4,513 epilepsy outpatients have
been referred to AmbuFlex, which are about two-thirds
of all epilepsy outpatients in the region. The PRO ques-
tionnaire used contains information on specific aspects
of daily life with epilepsy and has been developed in
close cooperation with clinicians and patients. Face val-
idity is fundamental and has been ensured during the
development of the questionnaire [12, 13]. A graphical
PRO overview is presented to the clinicians, who use the
PRO data for clinical decisions together with other avail-
able clinical data in the record to decide whether the pa-
tient needs a visit or not. If a PRO questionnaire is used to
evaluate the patient’s need for a hospital visit, the PRO
data must be obtained outside the hospital. This is called
tele-patient-reported outcome (telePRO) [12]. Experiences
from epilepsy outpatient clinics have shown that of 8,256
PRO-based contacts, 48% were handled without additional
contact to the patient other than the PRO questionnaire
[13]. A preliminary interview study has indicated that pa-
tients experience greater flexibility in care, the saving of
time, improved communication with the clinicians, and
increased knowledge about their own disease [13, 15].
The AmbuFlex method used at the three neurological
departments is called standard telePRO. In standard tel-
ePRO, regular scheduled visits are replaced with fixed
questionnaires at intervals similar to those of the former
pre-booked visits. A patient-initiated approach “open ac-
cess” telePRO has been developed in which patients have
access to their own PRO data and are able to initiate
contact with the clinic by filling in a PRO questionnaire.
A review by Whear et al. investigated the effectiveness
of patient-initiated clinics in chronic conditions in sec-
ondary care and included seven randomised trials. The
review found that the risk of harm from using the
patient-initiated clinic model is low in patients with
breast cancer, inflammatory bowel disease, and rheuma-
toid arthritis. The included studies found few significant
differences in clinical outcomes between traditional ap-
pointment scheduling and the patient-initiated follow-up
method. In four of the studies, the patient-initiated
model was associated with savings in clinician time and
resource use [2]. A review by Taneja et al. that included
five of the same randomised studies reached the same
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conclusion [16], while another review showed no signifi-
cant differences in psychological and health-related qual-
ity of life outcomes between consultant-led and patient-
initiated clinics. Patients have reported better satisfaction
in patient-initiated clinics compared to usual care [17].
The patient-initiated method used was broadly the same
in the studies included in the three reviews. Patients
could request clinical advice by calling the clinic and, if
necessary, arranging an appointment to see a clinician.
However, none of the included studies used PRO as the
main access point in the open access intervention, and
all studies contain methodological limitations [2, 16, 17].
Objectives
The aim of this study is to provide insight into the effects
of patient-initiated telePRO follow-up. The specific aims
are to compare resource utilisation, quality of care, and
the patient perspective of two outpatient follow-up activ-
ities: a) standard telePRO (fixed-interval telePRO follow-
up) and b) open access telePRO (patient-initiated telePRO
follow-up). We hypothesise that 1. Number of contacts is
less in open access telePRO, 2. Quality of care in open ac-
cess telePRO is at least as good as in standard telePRO,
and 3. Patient self-management and experiences in open
access telePRO are better than standard telePRO.
Methods
The study follows the (Additional file 1: SPIRIT check-
list): Standard protocol items for clinical trials [18].
Design
This study is a pragmatic two-arm randomised con-
trolled trial. Participants are randomly assigned to one
of two follow-up activities: (a) standard telePRO or (b)
open access teleRPO.
Study population
Participants are epilepsy outpatients recruited from the
epilepsy clinic at Aarhus University Hospital in Central
Denmark Region, Denmark.
Inclusion criteria
a) Age ≥ 15 years
b) Diagnosis or suspicion of epilepsy (IC-D 10 codes:
G40, Z033a, DR568 and DR568E)
c) Already referred to standard telePRO by a clinician
d) Able to answer the questionnaire via the Internet,
indicated by having answered the last questionnaire
via the Internet
Exclusion criterion
a) Referred to telePRO follow-up with proxy questionnaire.
Patients can be referred to a proxy questionnaire if they
have cognitive problems and need help from a relative
or health professionals.
Intervention
Reference group – standard telePRO
AmbuFlex (standard telePRO) is used in three epilepsy
outpatient clinics in Central Denmark Region. In stand-
ard telePRO, outpatient follow-up activity is determined
by a clinician and patients receive a questionnaire at
fixed intervals (3, 6, or 12 months). The questionnaire
includes information about aspect of daily life with epi-
lepsy such as seizures, symptoms, medication adherence,
and social aspects. Responses are automatically proc-
essed according to a specific algorithm and given a
“green”, “yellow”, or “red” status. A red status indicates
that the patient needs or wishes contact with the clinic,
a green status that the patient has no current need of at-
tention, while a yellow status indicates that the patient
may need to be seen in the clinic, but a clinician has to
decide whether further contact is needed. The patient
can always overrule a decision by requesting contact.
They can choose two different contact forms in the
questionnaire: telephone consultation or a face-to-face
consultation at the clinic. Non-responders get three re-
minders and are contacted if do not respond. Clinicians
keep track of incoming yellow and red responses, and
non-responders, and this information is presented on a
PRO alert list. The PRO overview (Fig. 1) is presented
graphically to the clinician within the electronic health
record system, and used as decision aid together with
other available health record information to decide
whether the patient needs a visit or not [13].
Intervention group – open access telePRO
In open access, contact to the outpatient clinic is initi-
ated by the patient by filling in a PRO questionnaire.
The same questionnaire is used as in standard telePRO,
but the patient decides when to respond. The patients
can access a PRO overview, “My Epilepsy”, customised
for patient use via a secure login at the Danish national
health website “Sundhed.dk”. The clinicians handle
questionnaires in the same way as in standard telePRO.
The open access website “My Epilepsy”: design and features
A prototype website, “My Epilepsy”, was developed to
collect PRO in patient-initiated outpatient follow-up.
The website was linked with the Danish National
Health Website ‘Sundhed.dk’. The website, “My Epi-
lepsy”, was customised for patient use and designed to
allow patients to: a) answer a PRO questionnaire to get
in contact with the clinic, b) view their personal PRO
data (previously questionnaire responses), c) view infor-
mation about the epilepsy questionnaire and specific
questions, and d) have access to contact information to
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the epilepsy outpatient clinic. A research team that in-
cluded, outpatients with epilepsy and experts in tele-
PRO, patient involvement, software technology, clinical
epilepsy, provided inputs to design the prototype web-
site. The research team developed the initial website
specifications, constructed the website, and elicited
feedback from epilepsy outpatients (n = 6), using cogni-
tive interviewing techniques to study the manner in
which the patients understood and responded to the
website. The interface is shown in Fig. 2. Patients
emphasised the importance of a user-friendly interface
with clear and concise information. Patients were inter-
ested in tracking change over time and in using the
website because it gave them the potential to communi-
cate with their clinicians at a time decided by them-
selves. They found it conceivable that access to their
previous questionnaires could give them a better under-
standing of their chronic disease. Finally, they pointed
out the need for a telephone number if they required
immediate contact. Patients had few problems assessing
and using the site.
The website consists of four core elements:
a) Answer questionnaire: Here, patients can answer the
epilepsy questionnaire when they need to get in
contact with the clinic. The questionnaire is the
same as in standard telePRO. When the patient has
completed the questionnaire, the response is
automatically sent as a red request to the PRO alert
list at the epilepsy clinic. The clinician assesses the
response and contacts the patient as soon as
possible. The clinic has reserved appointments in
their booking system to ensure that patients get a
quick appointment. As a “safety net”, patients have
to answer the questionnaire before twice the fixed
interval has elapsed. For example, if the patient is
referred with a 12-month interval, the patient has to
respond within two years. If not, the patient is
automatically sent a questionnaire, given a red
status, and is contacted by a clinician.
b) Previous answers: In this element, all of the patient’s
previous questionnaire responses are available.
Patients have access to a PRO overview interface
and specific and detailed questionnaire responses in
the same manner as the clinicians. The overview
interface is shown in Fig. 3. It is customised to
monitor selected PRO data and to illustrate changes
in health status over time. Colour codes indicate the
severity of the symptoms reported by the patient. A
red or orange bar indicates a self-reported problem,
a yellow bar some problem, and green bar indicates
no problems.
Fig. 1 Screen capture of the clinicians’ overview in epilepsy clinics accessed from the Electronic Health Record of Central Denmark Region [13].
The colour dots in the upper row indicate the result of the automated PRO algorithm (red: definite need of contact, yellow: possible need of
contact, green: no need of contact). Note that the colours of the bars have different meanings. The bars indicate the severity of the symptoms
reported by the patient. A red or orange bar indicates a self-reported problem, a yellow bar some problem, and a green bar indicates no
problems. Note: Labels were translated from Danish
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Fig. 3 PRO response overview customised to outpatients with epilepsy. A red or orange bar indicates a self reported problem, a yellow bar some
problem, and green bar indicates no problems. Note: Labels were translated from Danish
Fig. 2 The open access telePRO website “My Epilepsy”. Note: Labels were translated from Danish
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c) Info: This element includes information about the
open access approach including detailed information
about the purpose and how to use the website. In
addition, there is information about the questionnaire
and why it is important to gather information about
the included aspects, e.g., seizures, alcohol, pregnancy,
sexuality, etc. The information provided is compiled
by clinicians from the epilepsy clinics at Aarhus
University Hospital and is based on disease-specific
guidelines and information from the Danish Epilepsy
Association.
d) Contact: Patients are asked to contact the epilepsy
clinic by telephone in the event of a pressing need of
attention. This element contains contact information
(telephone number, email and mail addresses) to the
epilepsy clinic. The emergency service is always open
for those in acute need for help, for example, if the
patient gets a seizure.
Randomisation
Pre-randomisation designs prevent change in behaviour
in the control group because of disappointment about
the allocation [19]. Eligible standard telePRO partici-
pants will be pre-randomised to standard telePRO
follow-up (no change) or open access telePRO follow-
up. Control as well as intervention participants receive
the baseline questionnaire together with the fixed PRO
questionnaire. The clinicians respond to the fixed PROs
as usual and will not have access to the baseline ques-
tionnaire. Control participants will continue with fixed
interval questionnaires and no change will be under-
taken. Intervention participants will receive detailed in-
formation about the open access approach two weeks
after a clinician’s response to the fixed PRO question-
naire. The study coordinator will forward written
information to the included intervention participants.
Individuals who not agree to participate will continue
with standard telePRO follow-up. Due to the nature of
the intervention neither patients nor clinicians can be
blinded to allocation. The randomisation is performed
with an algorithm developed as part of the WestChronic
software [12]. The allocation ratio open access/standard
is 0.55/0.45. This ratio was selected to account for an ex-
pected number of patients in the open access arm who
do not wish to participate.
Study timeline
Inclusion and randomisation with baseline assessments
will take place from January 2016. Follow-up assessment
will take place 18 months after randomisation. Baseline
and follow-up assessments are shown in Table 1. Figure 4
presents the inclusion of patients and the stages in the
study.
Outcomes
The effects of patient-initiated follow-up (open access
telePRO) will be evaluated with regard to three different
aspects: resource utilisation, quality of care, and the pa-
tient perspective. Resource utilisation will constitute the
primary outcome, measured by number of contacts.
Quality of care and the patient perspective constitute
the secondary outcomes. Quality of care includes pivotal
clinical quality measures (mortality, seizure, and treat-
ment side effects) as well as more general patient-
oriented quality measures (well-being and general
health). The patient perspective includes measures re-
lated to self-management, such as health literacy, self-
efficacy, and patient activation. Measures of confidence,
safety, and satisfaction will be used to describe patient
experiences. The patient perspective is primarily
Table 1 Primary and secondary outcomes, data sources, and timeline for measurements
Outcomes Data sources Measurement/month
Resource utilisation
1. Number of contacts The Hospital Business Intelligence Register, Central Denmark Region 0–18
Quality of care
2. Well-being WHO-Five Well-being Index (WHO-5) 0, 18
3. General health Item from The Short Form Health Survey (SF-36) 0, 18
4. Mortality The Hospital Business Intelligence Register, Central Denmark Region 0–18
5. Number of seizures Item from the epilepsy questionnaire, Central Denmark Region 0, 18
6. Treatment side effects Item from the epilepsy questionnaire, Central Denmark Region 0, 18
Patient perspective a
7. Health literacy The Health Literacy Questionnaire (HLQ) sub scale 4, 6 and 9 0, 18
8. Self-efficacy General Self-Efficacy scale (GSE) 0, 18
9. Patient activation Items from Patient Activation Measure (PAM) 0, 18
10. Confidence, safety, and satisfaction Items from a PREM questionnaire, Danish Cancer Society 0, 18
a The patient perspective is primarily explored by qualitative methods in a complementary PhD study
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explored by qualitative methods in a complementary
PhD study. An overview of primary and secondary out-
comes, data sources, and measurement timeline is
shown in Table 1.
Primary outcome
Resource utilisation
Number of contacts includes all contacts with the out-
patient clinic in the study follow-up period, including
face-to-face consultations with a physician, face-to-face
consultations with a nurse, and telephone consultations.
In addition, other health care contacts will be gathered,
e.g., epilepsy-related emergency room visits and hospita-
lisations as well as hospitalisation related to co-
morbidity. Data will be gathered from the Hospital Busi-
ness Intelligence Register in Central Denmark Region.
Secondary outcomes
Quality of care
Patients’ well-being will be measured by using the Da-
nish version of WHO-Five Well-being Index (WHO-5).
WHO-5 was developed by the World Health Organisa-
tion for the assessment of well-being among patients
with diabetes [20]. WHO-5 consists of five positively
worded items reflecting present mental well-being
within the previous two weeks. Items are rated on a 6-
point scale ranging from 5 “all of the time” to 0 “at no
time”. The instrument has demonstrated sufficient psy-
chometric properties in a wide range of chronic condi-
tions [20, 21]. Patients’ general health will be measured
by using one item from the Danish version of The Short
Form Health Survey (SF-36); “In general, would you say
your health is: excellent, very good, good, fair, or poor”
[22, 23]. The validity and reliability of this item are well
documented [24]. Data on mortality will be gathered
from the Hospital Business Intelligence Register in Cen-
tral Denmark Region. Finally, number of seizures and
treatment side effects will be collected from ad hoc
items in the epilepsy questionnaire used at epilepsy
clinics in Central Denmark Region. The validity and reli-
ability of these items have not yet been documented.
Patient perspective
Health literacy will be measured by using the Danish
version of Health Literacy Questionnaire (HLQ) [25, 26].
HLQ was developed to measure a wide range of health
literacy needs of people in the community. The HLQ in-
cludes nine conceptually subscales with a total of 44
Fig. 4 Flowchart following patients from inclusion to final data collection
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items containing five scales with agree/disagree response
options and four scales with difficulties in perform tasks
response options. The HLQ has well-documented psy-
chometric properties [26]. In this study, the HLQ sub-
scales 4, 6, and 9 will be used; 4. Social support for
health, 6. Ability to actively engage with healthcare pro-
viders, 9. Understand health information well enough to
know what to do. Self-efficacy will be measured by using
the Danish version of General Self-Efficacy Scale (GSE)
[27, 28]. GSE was designed to assess optimistic self-
belief to cope with difficult demands in life [27, 28]. GSE
includes ten items with a response range from 1 “not at all
true” to 4 “exactly true”. The GSE scale has been used in a
range of research projects in different countries and popu-
lations, where it typically yielded sufficient psychometric
properties [29]. Patient activation will be measured by two
ad hoc items developed with inspiration from the Danish
version of the Patient Activation Measure (PAM) [30].
Confidence, safety, and satisfaction will be measured by
using ad hoc items developed with inspiration from a
Danish PREM (patient-reported experience measure)
questionnaire from the Danish Cancer Society.
In addition, the patient perspective will be explored in
a complementary qualitative PhD study. The primary
aim of this study is to explore the mechanisms of actions
related to standard telePRO and open access telePRO.
Interpretive description (ID) will be used as the research
approach [31]. Patients’ experiences with telePRO will
be explored in individual interviews and participant ob-
servations in outpatient clinics. The target group for par-
ticipation is patients with epilepsy, referred to standard
telePRO or open access telePRO follow-up in the three
neurological departments in Central Denmark Region.
Other measurements
Demographic information such as sex, age, education,
marital status, and duration of epilepsy diagnosis will be
obtained from baseline questionnaires.
Sample size
Statistical power was estimated for the primary outcome
number of contacts. Based on literature review [32] the
number of consultations (n) and standard deviation (SD)
was; n = 4.64, (SD = 2.38) in conventional follow-up and
n = 4.12, (SD = 3.41) in open access follow-up. We ex-
pect at least a difference of one contact between the
groups. Given a statistical power of 90%, p-value 0.05,
and allocation ratio 0.8, we will need a sample size of
172 patients in the standard telePRO group and 214 pa-
tients in the open access telePRO group. To account for
attrition and loss to follow-up, we will recruit a total of
approximately 500 participants. For qualitative data, a
purposeful sample of at least five participants from each
group will be interviewed.
Analyses
Descriptive statistics will be used to describe differences
in the baseline characteristics of participating patients in
the two arms of the trial. Statistical analysis will be
intention to treat, whereby all randomised participants
will be included in the analysis according to their rando-
mised allocation. The primary outcome, total number of
contacts in the two arms, will be analysed using a sample
t-test. If the distribution of data is skewed, we will use
medians and nonparametric tests. For secondary out-
comes, a chi-square test or logistic regression will be
used for dichotomous outcome data and sample t-test or
multiple linear regression analysis will be used for con-
tinuous outcome data. Non-parametric tests will be used
if continuous data are not normally distributed. Demo-
graphics covariates (sex, age, education, marital status,
and epilepsy diagnosis duration) will be included in the
per- protocol analysis.
For qualitative data, ID will be employed as the overrid-
ing research approach. ID is an inductive research strategy
in which constant comparative method with concurrent
data collection and analysis is utilised to gain a deeper
insight and understanding of human experiences within
their natural context. The result is a comprehensive inter-
pretation, potentially a model of explanation of the
phenomenon under study, which can provide clinical
practice with a research-based choice of action [31]. ID is
considered appropriate in the present study because the
approach is suited for exploration of specific clinical is-
sues, in this case how patients with epilepsy experience
standard and open access telePRO follow-up.
Ethics
The risks to participants are considered to be minimal
as all eligible participants are referred to standard tele-
PRO follow-up by clinicians at the epilepsy clinic. As a
“safety net” to ensure that no patients are lost in the
open access arm, the patients have to answer the epi-
lepsy questionnaire before twice the fixed interval has
elapsed. If lack of response the patient is reallocated into
standard telePRO with a red status and a clinician will
contact the patient. Furthermore, all patients are in-
formed to call the clinic in pressing need of attention.
The Danish Data Protection Agency has accepted the
study. In addition, the Danish research ethics committee
in Central Denmark Region was contacted and has
stated that approval from the committee is not necessary
for this present study. Therefore, written informed con-
sent was not obtained from the participants. Prior to
study participation patients in the intervention group re-
ceive written information about the study. Study participa-
tion is entirely voluntary and participants are informed they
can withdraw from the study at any time without affecting
future care. In the qualitative complementary PhD study,
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the participants gave written informed consent prior
to enrolment, and the study was approved by the Danish
Data Protection Agency.
Data security
All data activities in the study are documented and
stored in the WestChronic web-system [12]. The system
is physically located in Central Denmark Regions Server
Park behind the firewall and Threat Management Gate-
way. Regular backup is performed weekly. All data trans-
actions fulfill conditions established by the Danish Data
Protection Agency.
Discussion
During the last decade, the use of PRO in clinical practice
has become increasingly common, and to our knowledge,
AmbuFlex is the first generic PRO system that uses PRO
as the basis for outpatient follow-up [13]. The focus of this
trial will be to evaluate the effect of a patient-initiated
open access telePRO intervention compared to standard
telePRO with respect to resource utilisation, quality of
care, and the patient perspective. Ideally, we would have
preferred to compare the two arms (standard and open ac-
cess) with conventional follow-up with pre-booked out-
patient visits to the clinic. However, this was not possible
because the epilepsy clinics in Central Denmark Region
have used standard telePRO follow-up since 2012. Thus,
we will compare two rather similar outpatient follow-up
activities, which will probably result in only small differ-
ences in effect between the groups. Evaluation of the effect
must be done using reliable, valid, and clinically meaning-
ful measures. This study includes outcome measures
based on recommendations from clinical experts, re-
searchers, and the literature [33].
Loss to follow-up is one of the main concerns in ran-
domised controlled studies [34]. Loss to follow-up in this
study is related to the open access group of patients
since study participation in the open access arm is en-
tirely voluntary, and participants can choose to continue
with standard telePRO follow-up. Loss of statistical effi-
ciency can be overcome by increased the number of par-
ticipants in the study [19]. We have taken this into
consideration and will include 10% more patients in the
open access telePRO arm. In addition, we will recruit a
larger number of participants than the minimum sample
size calculation indicated.
Only web-responders will be included in the open ac-
cess arm, and the results may therefore be generalizable
only to this subgroup of epilepsy patients. These patients
may differ with respect to education, age, and use of new
technologies compared to the entire group of epilepsy pa-
tients. In another study in progress, the aim is to examine
determinants for referral to telePRO follow-up. Data from
this study can be used to compare the study population
with the entire group of patients with epilepsy.
Another potential challenge may be how individuals in
the intervention group will use the “My Epilepsy” website.
Some patients are better able to decide themselves when
they need to contact the clinic, while others are more re-
served and afraid to be a nuisance. Several patients that
have used standard telePRO have pointed out the benefit
of getting a fixed questionnaire once a year. They do not
believe they would remember to answer if they had to do
it on their own. This could signify that even though they
may not feel the need for a clinical appointment, but do
feel a form of security in answering the fixed interval
questionnaire. This will be taken into consideration in the
study, since all patients in the intervention group will re-
ceive a questionnaire if they do not respond within two
times the referred interval, for example, within 24 months
if they are assigned a 12-month questionnaire interval.
Another concern could be that patients in the open access
group could choose to make a call instead of answering
the questionnaire when they need to get in contact with
the clinic. If they behave in this way, the benefit of using
PRO in clinical practice will be reduced.
Standard telePRO has been well integrated into clinical
practice in three epilepsy clinics in Central Denmark Re-
gion since 2012. A new patient-initiated approach has
been developed that may result in potential benefits in
terms of the patient perspective and resource utilisation.
The potential benefits as well as possible drawbacks need
to be evaluated. We have decided to combine qualitative
and quantitative research methods in two parallel PhD
studies. The intention of the complementary qualitative
PhD study is to further explain the findings from the ran-
domised study by providing a description of the various
ways in which telePRO is manifested and an interpretation
of the underlying mechanisms of action. The two studies
will complement each other and contribute with import-
ant research-based knowledge to guide future telePRO in-
terventions in relation to effect on resource utilisation,
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